MET for Renal Colic


Playback Speed

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Juan G. -

So we've seen a few articles in the last couple of years citing tamusolin no better than placebo for MET. What none of these articles care to address is that tamusolin decreases ureteral spasm and therefore, pain. THIS is what causes patients to bounceback to the the ED. We all know what stones are likely to require urologic intervention, ie. size, location, etc. and which ones will likely pass on their own. If tamusolin has no effect on stone passage, quite frankly, I'm not concerned. I'd like to see a stone study whose primary outcome is failure of outpatient treatment: tamusloin+standard therapy (nsaids, narcotics, antiemetics) vs standard therapy alone. If it's shown that tamusolin does nothing to improve pain control and prevent bouncebacks, THEN I'm ready to kiss it goodbye. Until then, I'll continue to prescribe with the belief that I will be achieving better pain control for my patients, and preventing bouncebacks.
Juan MD

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.